Dark

Check out our Dark Pool Levels

ANCUST
Anoncoin / TerraUSD
crypto

Inactive

Apr 18, 2022 11:54:00 PM EDT

2.10UST+0.334%(+0.01)73,5680

Overview Historical DepthNews

Jan 28, 2022

08:01AM EST Updates on OLUMIANT(r) (baricitinib) Phase 3 lupus program and FDA review for PR Newswire

Jan 7, 2022

09:00AM EST Axial Spondyloarthritis to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) PR Newswire

Dec 14, 2021

04:08PM EST U.S. FDA Approves Pfizer's XELJANZ(r) (tofacitinib) for the Treatment of Active Ankylosing Spondylitis Business Wire

Nov 18, 2021

01:30PM EST Pfizer's XELJANZ(r) (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis Business Wire

Nov 9, 2021

08:31AM EST OLUMIANT(r) Long-Term Safety Profile Established Up to 9.3 Years in Integrated PR Newswire

Share